Recent Update on the Role of Circular RNAs in Hepatocellular Carcinoma.
HBV
HCC
biomarkers
ceRNA
circRNA
microRNA
signaling pathways
Journal
Journal of hepatocellular carcinoma
ISSN: 2253-5969
Titre abrégé: J Hepatocell Carcinoma
Pays: New Zealand
ID NLM: 101674775
Informations de publication
Date de publication:
2021
2021
Historique:
received:
28
10
2020
accepted:
17
12
2020
entrez:
5
2
2021
pubmed:
6
2
2021
medline:
6
2
2021
Statut:
epublish
Résumé
After being overlooked for decades, circular RNAs (circRNAs) have recently generated considerable interest. circRNAs play a role in a variety of normal and pathological biological processes, including hepatocarcinogenesis. Many circRNAs contribute to hepatocarcinogenesis through sponging of microRNAs (miRs) and disruption of cellular signaling pathways that play a part in control of cell proliferation, metastasis and apoptosis. In most cases, overexpressed circRNAs sequester miRs to cause de-repressed translation of mRNAs that encode oncogenic proteins. Conversely, low expression of circRNAs has also been described in hepatocellular carcinoma (HCC) and is associated with inhibited production of tumor suppressor proteins. Other functions of circRNAs that contribute to hepatocarcinogenesis include translation of truncated proteins and acting as adapters to regulate influence of transcription factors on target gene expression. circRNAs also affect hepatocyte transformation indirectly. For example, the molecules regulate immune surveillance of cancerous cells and influence the liver fibrosis that commonly precedes HCC. Marked over- or under-expression of circRNA expression in HCC, with correlating plasma concentrations, has diagnostic utility and assays of these RNAs are being developed as biomarkers of HCC. Although knowledge in the field has recently surged, the myriad of described effects suggests that not all may be vital to hepatocarcinogenesis. Nevertheless, investigation of the role of circRNAs is providing valuable insights that are likely to contribute to improved management of a serious and highly aggressive cancer.
Identifiants
pubmed: 33542907
doi: 10.2147/JHC.S268291
pii: 268291
pmc: PMC7851377
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
1-17Informations de copyright
© 2021 Ely et al.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest in this work.
Références
Clin Chim Acta. 2020 Jan;500:10-19
pubmed: 31604064
Mol Cancer. 2020 Jun 27;19(1):110
pubmed: 32593303
Cancer Manag Res. 2019 Dec 31;11:10957-10967
pubmed: 32099459
Cell Death Dis. 2020 Jun 12;11(6):452
pubmed: 32532962
J Cell Biochem. 2019 Feb 5;:
pubmed: 30719761
Onco Targets Ther. 2020 Aug 25;13:8615-8627
pubmed: 32904604
Cancer Biother Radiopharm. 2020 Jul 14;:
pubmed: 32673066
N Engl J Med. 2008 Jul 24;359(4):378-90
pubmed: 18650514
Oncogene. 2005 Mar 31;24(14):2375-85
pubmed: 15674322
Curr Epidemiol Rep. 2019 Jun;6(2):104-111
pubmed: 31259140
Cancer Cell Int. 2020 Jul 8;20:293
pubmed: 32669969
Mod Pathol. 2005 May;18(5):686-92
pubmed: 15605078
J Cell Biochem. 2020 Nov;121(11):4440-4449
pubmed: 32037619
J Med Genet. 2019 Jan;56(1):32-38
pubmed: 30120213
Aging (Albany NY). 2020 Feb 12;12(3):2485-2497
pubmed: 32048611
Cell Cycle. 2020 Apr;19(7):817-824
pubmed: 32116112
RNA. 2015 Feb;21(2):172-9
pubmed: 25449546
Cell Transplant. 2020 Jan-Dec;29:963689720948016
pubmed: 32787581
Arch Biochem Biophys. 2019 Jan;661:196-202
pubmed: 30468709
Biol Chem. 2019 Jan 28;400(2):247-253
pubmed: 30171807
J Cancer. 2019 Jun 9;10(15):3361-3372
pubmed: 31293639
Cancer Manag Res. 2019 Oct 24;11:9133-9143
pubmed: 31695501
Cell Cycle. 2019 May;18(9):976-989
pubmed: 30931701
Eur Rev Med Pharmacol Sci. 2019 Feb;23(2):555-566
pubmed: 30720163
Cancer Discov. 2016 Mar;6(3):235-46
pubmed: 26865249
Hepatology. 2018 Aug;68(2):723-750
pubmed: 29624699
Mol Oncol. 2019 Feb;13(2):441-455
pubmed: 30537115
J Clin Lab Anal. 2020 Jul;34(7):e23300
pubmed: 32319701
Cell Cycle. 2019 Nov;18(21):2939-2953
pubmed: 31522588
Int J Cancer. 2016 Oct 1;139(7):1534-45
pubmed: 27244487
Cancer Cell Int. 2019 Aug 8;19:211
pubmed: 31413665
Ann Hepatol. 2020 May - Jun;19(3):269-279
pubmed: 32089501
Ann Transl Med. 2020 Mar;8(6):294
pubmed: 32355738
Best Pract Res Clin Gastroenterol. 2005 Feb;19(1):25-37
pubmed: 15757803
Cancer Manag Res. 2020 Aug 18;12:7383-7394
pubmed: 32884351
Cell Rep. 2015 Jan 6;10(1):103-11
pubmed: 25543144
Clin Chem. 2019 Jun;65(6):798-808
pubmed: 30914410
J Hepatol. 2010 Mar;52(3):322-9
pubmed: 20133006
Hepat Mon. 2012 Oct;12(10 HCC):e7238
pubmed: 23162603
J Integr Bioinform. 2019 Jul 13;16(3):
pubmed: 31301674
Cell. 2014 Sep 25;159(1):134-147
pubmed: 25242744
Nature. 1979 Jul 26;280(5720):339-40
pubmed: 460409
Oncogene. 2018 Mar;37(13):1805-1814
pubmed: 29343848
Mol Cancer. 2019 Jun 1;18(1):105
pubmed: 31153371
Mol Cancer. 2020 May 19;19(1):92
pubmed: 32430013
Cold Spring Harb Perspect Med. 2015 Jul 17;5(9):a021535
pubmed: 26187874
Clin Exp Pharmacol Physiol. 2020 Jul;47(7):1291-1300
pubmed: 32017171
Onco Targets Ther. 2020 Aug 04;13:7773-7783
pubmed: 32801783
Aging (Albany NY). 2020 Jun 18;12(12):11623-11635
pubmed: 32554866
Nat Commun. 2017 Mar 30;8:14741
pubmed: 28358055
J Glob Infect Dis. 2009 Jan;1(1):33-7
pubmed: 20300384
Cancer Med. 2019 Apr;8(4):1423-1433
pubmed: 30714679
Database (Oxford). 2020 Jan 1;2020:
pubmed: 32219412
Cancer Cell Int. 2020 Aug 25;20:404
pubmed: 32863763
Cell Biol Int. 2020 Nov;44(11):2344-2356
pubmed: 32808701
Aging (Albany NY). 2019 Oct 1;11(19):8182-8203
pubmed: 31581132
Oncol Lett. 2019 Feb;17(2):2091-2098
pubmed: 30675276
J Cancer. 2020 Mar 5;11(11):3318-3326
pubmed: 32231737
J BUON. 2019 Nov-Dec;24(6):2402-2410
pubmed: 31983112
J Virol. 2019 Sep 30;93(20):
pubmed: 31375584
Hum Gene Ther Clin Dev. 2019 Dec;30(4):152-159
pubmed: 31368365
Mol Med Rep. 2020 Jun;21(6):2395-2404
pubmed: 32323783
Oncogene. 2018 Feb 1;37(5):555-565
pubmed: 28991235
J Clin Lab Anal. 2020 Jan;34(1):e23049
pubmed: 31556152
Cancer Med. 2019 Mar;8(3):1148-1156
pubmed: 30693679
J Exp Clin Cancer Res. 2020 Jun 17;39(1):114
pubmed: 32552766
Hepatology. 2019 Oct;70(4):1298-1316
pubmed: 31004447
Cancer Manag Res. 2019 Jan 03;11:443-454
pubmed: 30655696
Cell Prolif. 2019 Sep;52(5):e12635
pubmed: 31334580
Cancer Manag Res. 2020 Aug 04;12:6849-6860
pubmed: 32801909
Cell. 2015 Mar 12;160(6):1125-34
pubmed: 25768908
Methods Mol Biol. 2016;1418:93-110
pubmed: 27008011
Mol Oncol. 2020 Feb;14(2):447-461
pubmed: 31758671
Mol Cancer. 2019 Jul 19;18(1):119
pubmed: 31324186
Eur Rev Med Pharmacol Sci. 2020 Mar;24(5):2347-2357
pubmed: 32196586
Int J Cancer. 2020 Mar 15;146(6):1754-1763
pubmed: 31456215
Hepatology. 2020 Jan;71(1):130-147
pubmed: 31148183
Exp Ther Med. 2020 Apr;19(4):2733-2740
pubmed: 32226487
Mol Cancer. 2019 Aug 30;18(1):131
pubmed: 31470874
Nat Rev Genet. 2016 Oct 14;17(11):679-692
pubmed: 27739534
Cell Death Dis. 2019 Nov 27;10(12):900
pubmed: 31776329
Biomed Pharmacother. 2020 Jan;121:109517
pubmed: 31698267
J Cell Mol Med. 2020 May;24(9):5152-5161
pubmed: 32222024
Cancer Sci. 2019 Feb;110(2):568-581
pubmed: 30520539
Gene. 2019 Sep 25;714:143992
pubmed: 31330234
Nature. 2013 Mar 21;495(7441):333-8
pubmed: 23446348
Surg Oncol. 2020 Jun;33:276-281
pubmed: 32561093
Cell Death Dis. 2019 Sep 10;10(9):658
pubmed: 31506425
Clin Sci (Lond). 2019 Jul 15;133(13):1487-1503
pubmed: 31278132
J Natl Cancer Inst. 2018 Mar 1;110(3):
pubmed: 28903484
Cancer Cell Int. 2019 Dec 16;19:338
pubmed: 31889891
Hepatology. 2017 Oct;66(4):1151-1164
pubmed: 28520103
World J Gastroenterol. 2018 Oct 21;24(39):4436-4447
pubmed: 30357021
Onco Targets Ther. 2019 Jul 19;12:5849-5860
pubmed: 31410028
EBioMedicine. 2019 Feb;40:432-445
pubmed: 30630697
Genome Biol. 2014 Jul 29;15(7):409
pubmed: 25070500
Immunol Cell Biol. 2019 Feb;97(2):218-228
pubmed: 30302825
Gastroenterology. 2016 Sep;151(3):472-480.e1
pubmed: 27269245
Life Sci. 2020 Sep 15;257:118082
pubmed: 32653519
Dig Dis Sci. 2020 Jul 18;:
pubmed: 32683589
Cell Cycle. 2019 Oct;18(19):2398-2413
pubmed: 31095447
J Clin Lab Anal. 2020 Jul;34(7):e23359
pubmed: 32419229
Biomed Res Int. 2019 Nov 3;2019:8308694
pubmed: 31886256
Onco Targets Ther. 2020 Jun 29;13:6171-6180
pubmed: 32636641
Mol Ther Nucleic Acids. 2020 Sep 16;22:445-455
pubmed: 33230448
J Cell Mol Med. 2020 Sep;24(17):10216-10222
pubmed: 32692470
Biosci Rep. 2020 Jul 31;40(7):
pubmed: 32648571
J Cell Mol Med. 2020 Feb 20;:
pubmed: 32077624
Cancer Cell Int. 2020 Aug 3;20:360
pubmed: 32774154
Can J Gastroenterol Hepatol. 2019 May 2;2019:1684039
pubmed: 31187026
Cell Death Dis. 2019 Dec 10;10(12):945
pubmed: 31822654
Mol Ther Nucleic Acids. 2020 Sep 02;22:421-433
pubmed: 33230446
Philos Trans R Soc Lond B Biol Sci. 2017 Oct 19;372(1732):
pubmed: 28893941
J Cell Biochem. 2019 Jun;120(6):9487-9494
pubmed: 30556306
Oncol Lett. 2019 Jan;17(1):388-397
pubmed: 30655779
Biol Open. 2019 Sep 24;8(9):
pubmed: 31551242
Database (Oxford). 2019 Jan 1;2019:
pubmed: 31219565
Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):2957-2966
pubmed: 31315467
Nature. 2013 Mar 21;495(7441):384-8
pubmed: 23446346
Carcinogenesis. 2020 May 14;41(3):296-302
pubmed: 31535687
Lancet Gastroenterol Hepatol. 2019 Jul;4(7):545-558
pubmed: 30981686
J Cancer. 2020 Mar 4;11(10):2993-3001
pubmed: 32226514
Genome Biol. 2019 Apr 26;20(1):84
pubmed: 31027518
Cell Mol Life Sci. 2018 Mar;75(6):1071-1098
pubmed: 29116363
Cancer Manag Res. 2020 May 14;12:3457-3468
pubmed: 32523376
Front Physiol. 2018 Oct 09;9:1262
pubmed: 30356745
Nat Rev Genet. 2019 Nov;20(11):675-691
pubmed: 31395983
Front Cell Dev Biol. 2020 Jul 31;8:714
pubmed: 32850833
J Cell Physiol. 2020 Feb;235(2):1733-1745
pubmed: 31317555
Clin Lab. 2019 Nov 1;65(11):
pubmed: 31710441
Onco Targets Ther. 2020 May 21;13:4509-4521
pubmed: 32547082
J Hepatol. 2012 Jun;56(6):1384-91
pubmed: 22326465
Nat Commun. 2018 Oct 26;9(1):4475
pubmed: 30367041
Aging (Albany NY). 2020 May 28;12(10):9793-9806
pubmed: 32464601
Clin Chim Acta. 2019 May;492:37-44
pubmed: 30716279
Cancer Cell Int. 2020 May 29;20:202
pubmed: 32514247
Chin Med J (Engl). 2020 Aug 5;133(15):1774-1785
pubmed: 32675746
Gene. 2019 Jan 30;683:253-261
pubmed: 30342168
Biochem Biophys Res Commun. 2019 Jun 11;513(4):812-819
pubmed: 31000195
Cancer Cell Int. 2020 Jul 8;20:295
pubmed: 32669971
Medicine (Baltimore). 2016 May;95(22):e3811
pubmed: 27258521
Cell Death Dis. 2020 May 11;11(5):340
pubmed: 32393764
J Cell Physiol. 2021 Feb;236(2):1252-1269
pubmed: 32667692
Theranostics. 2019 May 26;9(12):3526-3540
pubmed: 31281495
Onco Targets Ther. 2020 May 29;13:4893-4903
pubmed: 32581550